These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 12478278

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
    Prabakaran P, Gan J, Wu YQ, Zhang MY, Dimitrov DS, Ji X.
    J Mol Biol; 2006 Mar 17; 357(1):82-99. PubMed ID: 16426633
    [Abstract] [Full Text] [Related]

  • 25. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P, Earl PL, Sironi F, Santoro F, Ripamonti C, Scarlatti G, Longhi R, Berger EA, Burastero SE.
    J Virol; 2005 Jun 17; 79(11):6957-68. PubMed ID: 15890935
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Structural elements of primary CCR5-using HIV-1 gp120 proteins influencing sensitivity and resistance to the broadly neutralizing monoclonal antibody b12.
    Sterjovski J, Churchill MJ, Ellett A, Wesselingh SL, Ramsland PA, Gorry PR.
    Virology; 2012 Oct 25; 432(2):394-404. PubMed ID: 22818780
    [Abstract] [Full Text] [Related]

  • 29. gp120: Biologic aspects of structural features.
    Poignard P, Saphire EO, Parren PW, Burton DR.
    Annu Rev Immunol; 2001 Oct 25; 19():253-74. PubMed ID: 11244037
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Improved design of an antigen with enhanced specificity for the broadly HIV-neutralizing antibody b12.
    Pantophlet R, Wilson IA, Burton DR.
    Protein Eng Des Sel; 2004 Oct 25; 17(10):749-58. PubMed ID: 15542540
    [Abstract] [Full Text] [Related]

  • 34. N-terminal residues 105-117 of HIV-1 gp120 are not involved in CD4 binding.
    el Ahmar W, Poumbourios P, McPhee DA, Kemp BE.
    AIDS Res Hum Retroviruses; 1991 Oct 25; 7(10):855-8. PubMed ID: 1720631
    [Abstract] [Full Text] [Related]

  • 35. Structural plasticity and conformational transitions of HIV envelope glycoprotein gp120.
    Korkut A, Hendrickson WA.
    PLoS One; 2012 Oct 25; 7(12):e52170. PubMed ID: 23300605
    [Abstract] [Full Text] [Related]

  • 36. HIV: Antibodies with a split personality.
    Plückthun A.
    Nature; 2010 Sep 30; 467(7315):537-8. PubMed ID: 20882002
    [No Abstract] [Full Text] [Related]

  • 37. B cell antigenic site mapping of HIV-1 glycoproteins.
    Neurath AR.
    Chem Immunol; 1993 Sep 30; 56():34-60. PubMed ID: 8452653
    [No Abstract] [Full Text] [Related]

  • 38. Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope.
    Darbha R, Phogat S, Labrijn AF, Shu Y, Gu Y, Andrykovitch M, Zhang MY, Pantophlet R, Martin L, Vita C, Burton DR, Dimitrov DS, Ji X.
    Biochemistry; 2004 Feb 17; 43(6):1410-7. PubMed ID: 14769016
    [Abstract] [Full Text] [Related]

  • 39. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.
    Klasse PJ, McKeating JA, Schutten M, Reitz MS, Robert-Guroff M.
    Virology; 1993 Sep 17; 196(1):332-7. PubMed ID: 8356803
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.